1,3-dichoro-1,2-propanediol (1,3-DCP) is a contaminant of acid-hydrolyzed vegetable protein and a chlorinated compound used in the fabrication of industrial products such as hard resins, celluloid or paints. Several reports have suggested that chronic exposure to 1,3-DCP could produce neurotoxicity in vitro or in neurobehavioral aspects of experimental animals. The present study further explored the in vitro neurotoxic effects of 0.1-100 µM 1,3-DCP on PC12 and N18D3 cell lines. In addition, to investigate the effects of repeated ingestions of 1,3-DCP on neurobehavioral impairments parameters in rats, locomotor activity and landing foot splay tests were preformed, following the treatment of 1,3-DCP at doses of 10, 20, and 30 mg/kg/day for 11 weeks. We demonstrated that no significant neurotoxic effects in vitro and in neurobehavior were observed in the 1,3-DCP-treated rats compared to saline-treated control rats, whereas, acrylamide, used as a positive control, induced significant increases of all neurobehavioral deficit parameters in both male and female rats. On the other hand, body weight gain was significantly decreased in high dose 1,3-DCP-treated male rats as well as in acrylamide-treated rats. Taken together, these results suggest that 1,3-DCP does not produce in vitro neurotoxicity and the neuromotor deficits, at the dose levels of this study. (J Toxicol Pathol 2004; 17: 37-41) 
Introduction
1,3-dichoro-1,2-propanediol (1,3-DCP) is a wellknown contaminant of hydrolyzed vegetable protein foodstuffs, including acid-hydrolyzed soy sauce. In addition, 1,3-DCP can be formed in some foods during cooking processes. Even now, a general population in many countries is consuming a considerable amount of 1,3-DCP from contaminated soy sauces or other food ingredients.
1,3-DCP has recently been associated with fulminant hepatitis in two workers cleaning a tank which had contained epichlorohydrin 1 . Other toxic effects of 1,3-DCP in humans include irritation of the mucous membranes, eyes and skin, as well as nausea and vomiting 2 . The metabolite 1,3dichloroacetone (1,3-DCA) was identified to be responsible for necrosis of the liver and other disorders 2, 3 . Similar effects were reported in rats 4, 5 . Several studies [6] [7] [8] also reported that cytochrome P450 2E1 and also 1A2 was involved in the formation of 1,3-DCA. Mechanisms accompanying direct toxicity of 1,3-DCA are lipid peroxidation 5, 6, 8 , glutathione depletion 5, 7, 9 and disruption of the mitochondrial membrane potential 4 .
Cell death in vitro or behavioral alterations in experimental animals in response to neurotoxic chemical often represent the earliest observable manifestation of toxicity. In this sense, the present study was designed to evaluate the early neurotoxic effects of 1,3-DCP using in vitro and neurobehavioral parameters. Hence, we explored the neurotoxic effect of 1,3-DCP at low exposure levels on PC12 and N18D3 cell lines. PC12 cells, derived from a transplantable rat pheochromocytoma, retain dopaminergic c h a r a c t e r i s t i c s a n d h a v e b e e n w i d e l y u s e d f o r neurotoxicological studies, and, N18D3 cells, generated by fusion of dorsal root ganglion neurons isolated from Balb/C mice with mouse neuroblastoma cells, exhibit neuron-like properties not displayed by the parental neuroblastoma 9 . In addition, to investigate the effects of repeated ingestions of 1,3-DCP on neurobehavioral impairments parameters in rats, locomotor activity and landing foot splay tests were preformed. Moreover, as a positive control, to show the n e u r o t o x i c e f f e c t s m o r e c l e a r l y , w e c o m p a r e d neurobehavioral effects of 1,3-DCP with those of acylamide (ACR), which is known to produce a significant hind limb deficit, lack of motor coordination, and muscular weakness 10 .
Materials and Methods

Cell cultures
PC12 cells and N18D3 cells (kindly provided by Dr. S. U. Kim) were used in this experiment. Cells were maintained in DMEM and F-12 nutrient (4:1) supplemented with 10% heat-inactivated horse serum, 5% fetal bovine serum, penicillin/streptomycin and 50 ng/ml nerve growth factor, in an incubator aerated with 95% air and 5% CO 2 at 37°C. All experiments were carried out within 96 h after cells were seeded.
Analysis of cell viability
The cell viability was determined using a modified MTT assay. In brief, cells were seeded in 96 well plates at a density of 1×10 4 cells/ml. The cultures were grown for 24 h, then the medium was added various concentrations of 1,3-DCP (0.1, 1, 10 or 100 µM). After incubation for a 24 h, 48 h or 72 h, 50 µl of a 2 mg/ml MTT solution in DMEM was added to the 96 well plates and the cells were incubated for 2 h at 37°C. After the medium had been removed, the cell and dye crystals were solubilized by adding 150 µl of dimethylsulfoxide (DMSO), and the absorption values was measured at 540 nm using an ELISA reader.
Animals
Adult male and female Sprague-Dawley rats (Charles River, Japan), weighing 225-250 g for male or 185-205 g for female, were used in this experiment. Control, DCP10, DCP20, DCP30 and ACR rats were given saline, 1,3-DCP at doses of 10, 20, and 30 mg/kg body weight, and ACR at dose of 30 mg/kg body weight (p.o.), respectively, on a daily basis for 11 weeks. Behavioral tests were undertaken on these rats at 1, 3, 5, 7, 9, and 11 weeks of exposure. The experiments were carried out according to the NIH guidelines for the care and use of laboratory animals and approved by the Institutional Animal Care and Use Committee of the Korea National Institute of Toxicological Research.
1. Motor activity: Ambulatory motor activity of individual rats was measured for a period of 10 min by using Optovarimex activity monitors (Columbus Instruments, USA) under dim light sound-attenuated conditions. Rats were recorded in an acrylic chamber surrounded by infrared sensors, which detect animal movements and send this information to a computer system. Each interruption of an infrared beam on the x-or y-axis generated an electric impulse that was measured and recorded on a computer.
2. Landing foot splay: The landing foot splay was measured according to the method described by Edwards and Parker 11 . The rat's feet painted with ink were dropped on a soft surface from a height of 30 cm, and the distance between the fourth digits of the two hind limbs was measured.
Statistical analysis
Mean numbers of each value in 1,3-DCP-treated and ACR-treated cases were compared to those of controls using one-way analysis of variance, followed by a post-hoc Duncan test. A P<0.05 value was considered to be statistically significant. Mean values were calculated together with the deviation for each mean value.
Results
In vitro cell viability
PC12 and N18D3 cells were treated with various concentrations of 1,3-DCP from 0.1 µM to 100 µM and incubated up to 72 h. PC12 cell viability, expressed as a percentage of the control group, was not significantly changed and did not show a dose-related effect with the treatment of 1,3-DCP (Fig. 1A) . In addition, the viability of N18D3 cell in 1,3-DCP-treated groups was not significantly different from that in control groups at 24 h, 48 h, or 72 h of exposure (Fig. 1B) . To investigate the effects of metabolic activation on the neurotoxicity of 1,3-DCP, we treated PC12 cells with 10 µM 1,3-DCP in the presence of 2 mg/ml of rat liver S9 fraction. Because of its own toxicity, S9 treatment on PC12 cells reduced cell viability in comparison with the S9-free control group. However, in the presence of an S9 fraction, treatment of PC12 cells with 1,3-DCP (10 µM) for 24 h did not cause significant changes in cell viability (Fig.  1C ).
Body weight
Overall, the body weight of control, MCPD, and ACRtreated animals increased gradually and progressively with age ( Fig. 2A, B) . Although a general effect of 10, 20 and 30 mg/kg 1,3-DCP treatment on body weight was not observed in both male and female rats. In contrast, ACR-treated male and female rats showed a significant reduction in mean body weight compared with the respective control groups throughout all experimental periods.
Locomotor activity
The effects of chronic administration of 1,3-DCP on locomotor activity in male and female rats are shown in Figs. 3A and 3B, respectively. 1,3-DCP treatments did not change significantly in locomotor activity in either male or female rats throughout the study preiod. However, when compared with the locomotor activity of saline-treated rats, the locomotor activity of male rats treated chronically with ACR gradually decreased with the increase of exposure duration. Moreover, locomotor activity of ACR-treated rats on weeks 9 and 11 decreased significantly compared with that of saline-treated rats (P<0.05). Furthermore, these effects of ACR were clearer in female rats, which showed a significant decrease of locomotor activity after 5 weeks of exposure ( Fig. 3B ).
Landing foot splay
T r e a t m e n t o f 1 , 3 -D C P , a t a n y o f t h e t h r e e concentrations, did not induce significant changes in landing 
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foot splay distance in males (Fig. 4A) or females (Fig. 4B) .
In contrast, when rats were treated with ACR at a concentration of 30 mg/kg body weight, a significant increase in landing foot splay distance was observed at 1, 3, and 5 weeks of exposure in males and 1 and 3 weeks of exposure in females. Furthermore, the hind limbs of ACRtreated rats showed total paralysis thereafter, so we could not measure the landing foot splay distance any further.
Discussion
The purpose of this study was to evaluate the in vitro neurotoxicity and the profile of neurobehavioral effects of 1,3-DCP and to compare these neurobehavioral effects with those of ACR. The results of our in vitro studies using PC12 or N18D3 cell lines showed that 1,3-DCP induced no apparent signs of cell death or neurotoxicity at any concentrations and at any incubation times studied. In addition, the effect of the metabolic activation system using a liver S9 fraction did not produce significant changes in cell viability.
There are few reports of 1,3-DCP exposure effects on cytotoxicity in vitro. A study 12 was demonstrated that primary chick embryonic midbrain cell cultures exposed to 0.01-10 µM 1,3-DCP and 5-10 mM 1,3-DCA for 48-96 h exhibited that no differences in effects on differentiation were observed in mesencephalon cell cultures with 1,3-DCP and its metabolite 1,3-DCA. Also, our data obtained from PC12 and N18D3 cell cultures at relatively low concentrations (0.1-100 µM) of 1,3-DCP showed no evidence for neurotoxicity, i.e. cell death, or dose-related effects.
1,3-DCP is known to be hepatotoxic, nephrotoxic, mutagenic, and carcinogenic [1] [2] [3] [4] [5] [6] 8, 13, 14 . And, a study (15, 30 , 60 mg/kg bw/day for 13 weeks) was demonstrated that the no-effect dose for toxicological effects were considered to be 15 mg/kg bw/day for SD rat. But the histopathological change (liver, kidney) that could be related to treatment were not observed in treated groups 6 . However, any studies also suggest that chronic exposure to 1,3-DCP could produce neurotoxicity in vivo. Therefore, we suggest that in our study, exposure to 1,3-DCP for 11 weeks did not significantly change the ambulatory movement and landing foot spray distance throughout the tested period. In contrast, ACR-treated rats showed significant increases in these neurobehavioral deficit parameters and significant decrease in body weight gains compared to the saline-treated control group. Furthermore, ACR-treated rats showed severe hind limb paralysis after 7 and 5 weeks of exposure in male and female rats, respectively.
There are no significant differences in neurobehavioral parameters between 1,3-DCP-treated male and female rats. On the other hand, ACR treatment data suggest that female rats are more susceptible to ACR-induced neuromotor deficit effects than male rats. We think that further investigations are necessary to elucidate the sex difference on ACR susceptibility and to discover the mechanism of action in detail. In conclusion, the results of the present study suggest that 1,3-DCP treatment dose not produce the in vitro neurotoxic cell death and neuromotor deficits, at the dose levels and for the duration of this study. 
